Papers
(The H4-Index of Molecular Therapy-Oncolytics is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
| ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma | 24 |
| Oncolytic adenovirus for treatment of malignant ascites | 24 |